Literature DB >> 28534940

The Wnt regulator SFRP4 inhibits mesothelioma cell proliferation, migration, and antagonizes Wnt3a via its netrin-like domain.

Vanathi Perumal1, Arun M Dharmarajan2, Simon A Fox1.   

Abstract

Secreted frizzled related proteins (SFRPs) are a family of Wnt regulators which are frequently downregulated in cancers. In malignant mesothelioma (MM), downregulation of SFRP4 has been reported as a mechanism which contributes to aberrant activation of oncogenic Wnt signaling. Here we investigated the biological consequences of SFRP4 in two mesothelioma cell models where this protein is downregulated. We used recombinant SFRP4 and transient overexpression to study changes in proliferation, migration and downstream signaling. We found that recombinant SFRP4 inhibited both proliferation and migration of MM cells as well as abrogating the stimulatory effect of recombinant Wnt3a. Morphologically SFRP4 induced a cytotoxic effect distinct from apoptosis and consistent with mitotic catastrophe. Overexpression of SFRP4 in these cell lines displayed similar effects as endogenous protein on cell viability, migration and nuclear morphology. We also used expression constructs to examine the role of the SFRP4 cysteine rich domain (CRD) and a netrin-like domain (NLD) in these effects. Interestingly, we found it was the NLD which mediated the biological effects of SFRP4 in these cells. Our results indicate that SFRP4 inhibits mesothelioma proliferation, migration and activates alternative cell death pathways. The finding that the NLD is responsible for these has broader implications for this protein family. Overall this study suggests that the Wnt pathway may prove a promising target for therapy in mesothelioma.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28534940     DOI: 10.3892/ijo.2017.4011

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

1.  Delivery of expression constructs of secreted frizzled-related protein 4 and its domains by chitosan-dextran sulfate nanoparticles enhances their expression and anti-cancer effects.

Authors:  Vanathi Perumal; Frank Arfuso; Yan Chen; Simon Fox; Arun M Dharmarajan
Journal:  Mol Cell Biochem       Date:  2017-11-28       Impact factor: 3.396

2.  Investigation of Key Genes and Pathways in Inhibition of Oxycodone on Vincristine-Induced Microglia Activation by Using Bioinformatics Analysis.

Authors:  Wei Liu; Jishi Ye; Hong Yan
Journal:  Dis Markers       Date:  2019-02-10       Impact factor: 3.434

3.  Dopamine D2 receptor modulates Wnt expression and control of cell proliferation.

Authors:  Fei Han; Prasad Konkalmatt; Chaitanya Mokashi; Megha Kumar; Yanrong Zhang; Allen Ko; Zachary J Farino; Laureano D Asico; Gaosi Xu; John Gildea; Xiaoxu Zheng; Robin A Felder; Robin E C Lee; Pedro A Jose; Zachary Freyberg; Ines Armando
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

4.  lncRNAS56464.1 as a ceRNA promotes the proliferation of fibroblast‑like synoviocytes in experimental arthritis via the Wnt signaling pathway and sponges miR‑152‑3p.

Authors:  Hui Jiang; Jian Liu; Chang Fan; Jing Wang; Weiping Li
Journal:  Int J Mol Med       Date:  2021-01-15       Impact factor: 4.101

5.  Tumor suppressor role of sFRP‑4 in hepatocellular carcinoma via the Wnt/β‑catenin signaling pathway.

Authors:  Quanxin Wu; Cheng Xu; Xianghua Zeng; Zhimin Zhang; Bo Yang; Zhiguo Rao
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

6.  SFRP Tumour Suppressor Genes Are Potential Plasma-Based Epigenetic Biomarkers for Malignant Pleural Mesothelioma.

Authors:  Yuen Yee Cheng; Ellie Mok; Sarah Tan; Catherine Leygo; Chris McLaughlin; A M George; Glen Reid
Journal:  Dis Markers       Date:  2017-12-13       Impact factor: 3.434

7.  Modulation of Calretinin Expression in Human Mesothelioma Cells Reveals the Implication of the FAK and Wnt Signaling Pathways in Conferring Chemoresistance towards Cisplatin.

Authors:  Janine Wörthmüller; Valérie Salicio; Anne Oberson; Walter Blum; Beat Schwaller
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.